大葉大學圖書館 |

Pharmaceutical innovation :incentives, competition, and cost-benefit analysis in international perspective /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	338.4/76151
書名/作者:	Pharmaceutical innovation : : incentives, competition, and cost-benefit analysis in international perspective // edited by Frank A. Sloan, Chee-Ruey Hsieh.
其他作者:	Sloan, Frank A.,
面頁冊數:	1 online resource (xiv, 331 pages) : : digital, PDF file(s).
附註:	Title from publisher's bibliographic system (viewed on 05 Oct 2015).
標題:	Pharmaceutical policy.
標題:	Pharmaceutical industry.
標題:	Drug development - Technological innovations
ISBN:	9780511618871 (ebook)
內容註:	Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux [and others] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh [and others] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh.
摘要、提要註:	The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.
電子資源:	http://dx.doi.org/10.1017/CBO9780511618871

Pharmaceutical innovation :incentives, competition, and cost-benefit analysis in international perspective /
Pharmaceutical innovation :incentives, competition, and cost-benefit analysis in international perspective /edited by Frank A. Sloan, Chee-Ruey Hsieh. - 1 online resource (xiv, 331 pages) :digital, PDF file(s).

Title from publisher's bibliographic system (viewed on 05 Oct 2015).

Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux [and others] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh [and others] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh.

The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.

ISBN: 9780511618871 (ebook)Subjects--Topical Terms:

376574
Pharmaceutical policy.

LC Class. No.: RA401.A1 / P43 2007

Dewey Class. No.: 338.4/76151

Pharmaceutical innovation :incentives, competition, and cost-benefit analysis in international perspective /
LDR:03283nam a22003018i 4500 001 449152
003 UkCbUP
005 20151005020621.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 161201s2007||||enk o ||1 0|eng|d
020 $a 9780511618871 (ebook)
020 $z 9780521874908 (hardback)
020 $z 9781107460010 (paperback)
035 $a CR9780511618871
040 $a UkCbUP $b eng $e rda $c UkCbUP
050 0 0 $a RA401.A1 $b P43 2007
082 0 0 $a 338.4/76151 $2 22
245 0 0 $a Pharmaceutical innovation : $b incentives, competition, and cost-benefit analysis in international perspective / $c edited by Frank A. Sloan, Chee-Ruey Hsieh.
264 1 $a Cambridge : $b Cambridge University Press, $c 2007.
300 $a 1 online resource (xiv, 331 pages) : $b digital, PDF file(s).
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Title from publisher's bibliographic system (viewed on 05 Oct 2015).
505 0 $a Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux [and others] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh [and others] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh.
520 $a The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.
650 0 $a Pharmaceutical policy. $3 376574
650 0 $a Pharmaceutical industry. $3 376576
650 0 $a Drug development $x Technological innovations $x Economic aspects. $3 644460
700 1 $a Sloan, Frank A., $e editor. $3 644458
700 1 $a Hsieh, Chee-Ruey, $e editor. $3 644459
776 0 8 $i Print version: $z 9780521874908
856 4 0 $u http://dx.doi.org/10.1017/CBO9780511618871